Digitisation of Healthcare Products and the Democratization Continuum of the Healthcare System in China : A Systematic Review

Authors

  • Henry Asante Antwi  School of Management, Jiangsu University, 301 Xuefu Road, Zhenjiang, P.R. China
  • Tamires Lizandra Andrade Paixao  Future Academy of Science and Technology, 3768 Hunan Highway, Shanghai, P.R China
  • Maxwell Opuni Antwi  School of Management, Jiangsu University, 301 Xuefu Road, Zhenjiang, P.R. China

DOI:

https://doi.org//10.32628/IJSRSET218446

Keywords:

E-Commerce, digital marketplace, Systematic Reviews and Meta-Analyses, Quality of Reporting of Meta-Analyses, PRISMA Model

Abstract

Typical of most industries, digitisation of healthcare products, services and models of E-Commerce is democratizing the current healthcare system in China while unlocking new previously inaccessible healthcare segments. This monumental convergence of healthcare industry with IT is part of a larger evolution and growth of E-Commerce from simple search portals for purchasing goods and services to more integrated digital marketplace that incorporates personalized experience and informed purchase decision making into online behaviours. The result is the manifestation of a new era of healthcare consumerism, as healthcare customers demand retail-like buying experience. We performed a comprehensive systematic scoping review of published data to identify how E-Commerce is complementing the traditional healthcare delivery system in China. We note that healthcare E-Commerce is facilitating the reconstruction of the healthcare value chain in China and at the same time is helping health facilities to reengineer operations and service processes. Our study highlights the important role E-commerce is playing in the healthcare industry in China.

References

  1. X. Zhu, "China's Technology Innovators," Management for Professionals, 2018.
  2. R. Thiebaut, "AI Revolution: How Data Can Identify and Shape Consumer Behavior in E-Commerce," in Entrepreneurship and Development in the 21st Century, ed: Emerald Publishing Limited, 2019, pp. 191-229.
  3. X. Wang, H. Yu, and S. Yu, "Analysis on the Status Quo of Health Food Purchase for Overseas Tourists in China," in 2018 International Workshop on Education Reform and Social Sciences (ERSS 2018), 2019.
  4. X. Zhu, "Case V: 3DMed: Digital Technology—Navigating Precision Medicine Towards Success," in Emerging Champions in the Digital Economy, ed: Springer, 2019, pp. 161-194.
  5. A. L. Foster, "COMPETITION LAW AND PHARMA: CHINA," in EU LAW OF COMPETITION AND TRADE IN THE PHARMACEUTICAL SECTOR, ed: Edward Elgar Publishing, 2019.
  6. X. Chen, "The Current Status and Development Countermeasures of Online Pharmacies in China," Open Journal of Social Sciences, vol. 6, p. 224, 2018.
  7. H. A. Antwi, Z. Lulin, E. A. Antwi, B. Kusi, T. Mustafa, and Z. Abdullai, "Deciding with the Crowd Wisdom: An Overview of Issues Facing the Corporate Application of Prediction Markets," 2017.
  8. L. Zhao, Q. Liu, and Y. Wang, "Development status and suggestions for e-commerce platform of traditional Chinese medicine in Henan Province," in IOP Conference Series: Earth and Environmental Science, 2019, p. 012038.
  9. A. Sethi, "Digital China," in Chinese Consumers, ed: Springer, 2019, pp. 33-54.
  10. C. Li and Z. Huang, "Evolutionary Game Analysis of Online and Offline Drug Retailer Competition Based on Network Externalities," IEEE Access, vol. 7, pp. 96620-96627, 2019.
  11. Z. Lulin, E. Yiranbon, and H. Asante Antwi, "Complementarity of clinician judgment and evidence based models in medical decision making: antecedents, prospects, and challenges," BioMed research international, vol. 2016, 2016.
  12. D. He, W. Zhang, G. Han, and T. Wu, "Productivity Growth of the Nontradable Sectors in China," Review of Development Economics, vol. 18, pp. 655-666, 2014.
  13. X. Xu, L. Zhou, H. A. Antwi, and X. Chen, "Evaluation of health resource utilization efficiency in community health centers of Jiangsu Province, China," Human resources for health, vol. 16, p. 13, 2018.
  14. X. Zhang, X. Yan, X. Cao, Y. Sun, H. Chen, and J. She, "The role of perceived e-health literacy in users’ continuance intention to use mobile healthcare applications: an exploratory empirical study in China," Information Technology for Development, vol. 24, pp. 198-223, 2018.
  15. G. M. Nayyar, J. G. Breman, T. K. Mackey, J. P. Clark, M. Hajjou, M. Littrell, et al., "Falsified and substandard drugs: Stopping the pandemic," The American journal of tropical medicine and hygiene, vol. 100, pp. 1058-1065, 2019.
  16. E. Hwang, X. Guo, Y. Tan, and Y. Dang, "Mobilizing Healthcare across Geography through Telemedicine Consultations," in ICIS, 2018.
  17. P. T. Whitacre, E. Kameyama, F. Carrero-Martínez, E. National Academies of Sciences, and Medicine, "Impact of E-Commerce, New Tools, Policies, and Measures," in Reducing Impacts of Food Loss and Waste: Proceedings of a Workshop, 2019.
  18. C. Cambini, A. Giusti, and M. Faccini, "Innovazione digitale e Cross-border e-commerce in Cina Digital innovation and Cross-border e-commerce in China," 2018.
  19. H. Yingfeng, "" Internet Plus" medical services based on total quality management theory: an empirical research in public hospital outpatient services in Guangzhou, China," 2018.
  20. P. Xiao, "Legislative Development of Food E-Commerce Regulation in China and Its Challenges," Eur. Food & Feed L. Rev., vol. 13, p. 313, 2018.
  21. F. Hao, D.-S. Park, X. Yin, X. Wang, and V. Phonexay, "A location-sensitive over-the-counter medicines recommender based on tensor decomposition," The Journal of Supercomputing, vol. 75, pp. 1953-1970, 2019.
  22. X. Wu, "" Medical+ internet" concept stock investment analysis," 2018.
  23. H. Lin, D. Xiao, Z. Liu, Q. Shi, P. Hajek, and C. Wang, "National survey of smoking cessation provision in China," Tobacco Induced Diseases, vol. 17, 2019.
  24. J. Cunliffe, D. Décary-Hêtu, and T. A. Pollak, "Nonmedical prescription psychiatric drug use and the darknet: A cryptomarket analysis," International Journal of Drug Policy, 2019.
  25. B. J. Venhuis, A. E. Oostlander, D. Di Giorgio, R. Mosimann, and I. du Plessis, "Oncology drugs in the crosshairs of pharmaceutical crime," The Lancet Oncology, vol. 19, pp. e209-e217, 2018.
  26. J. Sun and J. Buijs, "Online Food Regulation in China," Eur. Food & Feed L. Rev., vol. 13, p. 503, 2018.
  27. L. Hu, Z. Yu, Q. Yuan, Y. Hu, and C. O. L. Ung, "Opportunities and Challenges of Multinational Pharmaceutical Enterprises in Transforming Pharmaceutical Market in China," Therapeutic innovation & regulatory science, vol. 53, pp. 207-214, 2019.
  28. G. Z. Jin, "Price and Quality of Prescription Drugs," NBER Reporter, vol. 2018, p. 12, 2018.
  29. B. Niu, J. Wang, C. K. Lee, and L. Chen, "“Product+ logistics” bundling sale and co-delivery in cross-border e-commerce," Electronic Commerce Research, pp. 1-27, 2019.
  30. Y. Hu and B. Xu, "The Research of the Each Other Support between Online Sales and Offline Store based on the Marketing Mix," in 1st International Conference on Business, Economics, Management Science (BEMS 2019), 2019.
  31. Z. Qinghua, S. Wang, Y. Zhang, and K. He, "Research on supervision system of prescription drug e-commerce," in 2018 13th IEEE Conference on Industrial Electronics and Applications (ICIEA), 2018, pp. 411-416.
  32. J. Xu and P. Wu, "Research on the Current Situation and Strategy of E-commerce Development of Chinese Medicinal Materials in Gansu Province," in MATEC Web of Conferences, 2018, p. 05014.
  33. Z. Tao, Z. Yao, H. Kong, F. Duan, and G. Li, "Spatial accessibility to healthcare services in Shenzhen, China: improving the multi-modal two-step floating catchment area method by estimating travel time via online map APIs," BMC health services research, vol. 18, p. 345, 2018.
  34. R. Limaye, L. Kumar, and N. Limaye, "Fourth generation technologies in pharmaceuticals-Revolutionizing healthcare," Journal of Systems Biology & Proteome Research, vol. 2, 2018.
  35. K. Y. Wang and T. L. Yip, "Cold-chain systems in China and value-chain analysis," in Finance and risk management for international logistics and the supply chain, ed: Elsevier, 2018, pp. 217-241.
  36. J. Huang, "Contract Research Organizations Are Seeking Transformation in the Pharmaceutical Value Chain," ed: ACS Publications, 2019.
  37. J. Shi, D. Yi, and J. Kuang, "Pharmaceutical Supply Chain Management System with Integration of IoT and Blockchain Technology," in International Conference on Smart Blockchain, 2019, pp. 97-108.
  38. X. Chen, H. Yang, and X. Wang, "Effects of price cap regulation on the pharmaceutical supply chain," Journal of Business Research, vol. 97, pp. 281-290, 2019.
  39. X. Xi, Y. Huang, Q. Lu, C. O. L. Ung, and H. Hu, "Community pharmacists’ opinions and practice of pharmaceutical care at chain pharmacy and independent pharmacy in China," International journal of clinical pharmacy, vol. 41, pp. 478-487, 2019.
  40. J.-Z. Wu and Y.-C. Hsu, "Decision analysis on entering the China pharmaceutical market: Perspectives from Taiwanese companies," Computers & Industrial Engineering, vol. 125, pp. 751-763, 2018.
  41. L. Zhang, Y. Guo, and G. Sun, "How patent signals affect venture capital: The evidence of bio-pharmaceutical start-ups in China," Technological Forecasting and Social Change, vol. 145, pp. 93-104, 2019.
  42. M. Zhang, J. Zhang, T. Cheng, G. Hua, X. Yan, and Y. Liu, "The effect of unannounced inspection on prevention of drug fraud," Journal of Systems Science and Systems Engineering, vol. 28, pp. 63-90, 2019.
  43. Y. He, G. Dou, Q. Huang, X. Zhang, Y. Ye, M. Qian, et al., "Does the leading pharmaceutical reform in China really solve the issue of overly expensive healthcare services? Evidence from an empirical study," PloS one, vol. 13, p. e0190320, 2018.
  44. Z. Li, Q. Feng, J. A. Kabba, C. Yang, J. Chang, M. Jiang, et al., "Prices, availability and affordability of insulin products: a cross?sectional survey in Shaanxi Province, western China," Tropical Medicine & International Health, vol. 24, pp. 43-52, 2019.
  45. D. Hipgrave and Y. Mu, "Health System in China," Health Services Evaluation, pp. 779-807, 2019.
  46. S. Gong, H. Cai, Y. Ding, W. Li, X. Juan, J. Peng, et al., "The availability, price and affordability of antidiabetic drugs in Hubei province, China," Health policy and planning, vol. 33, pp. 937-947, 2018.
  47. D. R. Xu, W. Gong, E. D. Caine, S. Xiao, J. P. Hughes, M. Ng, et al., "Lay health supporters aided by a mobile phone messaging system to improve care of villagers with schizophrenia in Liuyang, China: protocol for a randomised control trial," BMJ open, vol. 6, p. e010120, 2016.
  48. J. Liao, Y. Chen, Y. Cai, N. Zhan, S. Sylvia, K. Hanson, et al., "Using smartphone-based virtual patients to assess the quality of primary healthcare in rural China: protocol for a prospective multicentre study," BMJ open, vol. 8, p. e020943, 2018.
  49. J. Tu, C. Wang, and S. Wu, "The internet hospital: an emerging innovation in China," The Lancet Global Health, vol. 3, pp. e445-e446, 2015.
  50. C. Yang, L. Wu, W. Cai, W. Zhu, Q. Shen, Z. Li, et al., "Current situation, determinants, and solutions to drug shortages in Shaanxi Province, China: a qualitative study," PloS one, vol. 11, p. e0165183, 2016.
  51. Y. Fang, "Pharmaceutical pricing policies in China," in Pharmaceutical Prices in the 21st Century, ed: Springer, 2015, pp. 43-58.
  52. J. Dai, X. Wang, and F. J. Ayala, "Medical informatics and the “three long, one short” problem of large urban hospitals in China," Jama, vol. 316, pp. 269-270, 2016.
  53. J. Hu and E. Mossialos, "Pharmaceutical pricing and reimbursement in China: when the whole is less than the sum of its parts," Health policy, vol. 120, pp. 519-534, 2016.
  54. Y. Chi, C. Yu, X. Qi, and H. Xu, "Knowledge Management in Healthcare Sustainability: A Smart Healthy Diet Assistant in Traditional Chinese Medicine Culture," Sustainability, vol. 10, p. 4197, 2018.
  55. Y. C. Dai Su, H. Gao, H. Li, L. Shi, J. Chang, X. H. Di Jiang, et al., "Does capitation prepayment based Integrated County Healthcare Consortium affect inpatient distribution and benefits in Anhui Province, China? An interrupted time series analysis," International journal of integrated care, vol. 19, 2019.
  56. W. Fan, J. Liu, S. Zhu, and P. M. Pardalos, "Investigating the impacting factors for the healthcare professionals to adopt artificial intelligence-based medical diagnosis support system (AIMDSS)," Annals of Operations Research, pp. 1-26, 2018.
  57. Y. Yang, X. Zhou, S. Gao, H. Lin, Y. Xie, Y. Feng, et al., "Evaluation of electronic healthcare databases for post-marketing drug safety surveillance and pharmacoepidemiology in China," Drug safety, vol. 41, pp. 125-137, 2018.
  58. S. Guo, X. Guo, X. Zhang, and D. Vogel, "Doctor–patient relationship strength’s impact in an online healthcare community," Information Technology for Development, vol. 24, pp. 279-300, 2018.
  59. H. Yang and H. Gao, "Toward sustainable virtualized healthcare: extracting medical entities from Chinese online health consultations using deep neural networks," Sustainability, vol. 10, p. 3292, 2018.
  60. D. He, R. Ye, S. Chan, M. Guizani, and Y. Xu, "Privacy in the Internet of Things for smart healthcare," IEEE Communications Magazine, vol. 56, pp. 38-44, 2018.
  61. Y. A. Hong and Z. Zhou, "A profile of eHealth behaviors in China: Results from a national survey show a low of usage and significant digital divide," Frontiers in public health, vol. 6, p. 274, 2018.
  62. B. Xu, L. Li, D. Hu, B. Wu, C. Ye, and H. Cai, "Healthcare data analysis system for regional medical union in smart city," Journal of Management Analytics, vol. 5, pp. 334-349, 2018.
  63. X. Li, L. Fan, and S. X. Leng, "The aging tsunami and senior healthcare development in China," Journal of the American Geriatrics Society, vol. 66, pp. 1462-1468, 2018.
  64. Q. Liu, K. Liao, and Z. Wei, "Automatic Acceptance Prediction for Answers in Online Healthcare Community," in 2018 IEEE International Conference on Bioinformatics and Biomedicine (BIBM), 2018, pp. 1262-1265.
  65. W. Zhang, Z. Deng, Z. Hong, R. Evans, J. Ma, and H. Zhang, "Unhappy patients are not alike: content analysis of the negative comments from China's Good Doctor website," Journal of medical Internet research, vol. 20, p. e35, 2018.
  66. S. Negash, P. Musa, D. Vogel, and S. Sahay, "Healthcare information technology for development: improvements in people’s lives through innovations in the uses of technologies," ed: Taylor & Francis, 2018.
  67. T. Q. Sun and R. Medaglia, "Artificial Intelligence Entering Public Healthcare Ecosystems: Do Policies Matter?," in 2017 Pre-ICIS Workshop on e-Government, 2018.
  68. T. Q. Sun and R. Medaglia, "Mapping the challenges of Artificial Intelligence in the public sector: Evidence from public healthcare," Government Information Quarterly, vol. 36, pp. 368-383, 2019.
  69. D. Tao, J. Yuan, F. Shao, D. Li, Q. Zhou, and X. Qu, "Factors affecting consumer acceptance of an online health information portal among young internet users," CIN: Computers, Informatics, Nursing, vol. 36, pp. 530-539, 2018.
  70. B. Wu, "Patient continued use of online health care communities: web mining of patient-doctor communication," Journal of medical Internet research, vol. 20, p. e126, 2018.

International Journal of Scientific Research in Science, Engineering and Technology

Downloads

Published

2021-08-30

Issue

Volume 8, Issue 4, July-August-2021

Section

Research Articles

License

Copyright (c) IJSRSET

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite

[1]
Henry Asante Antwi, Tamires Lizandra Andrade Paixao, Maxwell Opuni Antwi, " Digitisation of Healthcare Products and the Democratization Continuum of the Healthcare System in China : A Systematic Review, International Journal of Scientific Research in Science, Engineering and Technology(IJSRSET), Print ISSN : 2395-1990, Online ISSN : 2394-4099, Volume 8, Issue 4, pp.266-283, July-August-2021. Available at doi : https://doi.org/10.32628/IJSRSET218446